Bain Capital Life Sciences Investors, LLC
13F Portfolio Filings
- Most recent 13FQ4 2024
- Locationboston, MA
- CIK0001703031
- All SEC filings
Quater | Holdings | VALUE | Top Holdings | Form Type | Date Filed | Filing Id | |
|---|---|---|---|---|---|---|---|
26 | $850.10M | NEWAMSTERDAM PHARMA COMPANY, NUVL, PHARVARIS N V, IRON | 13F-HR | Feb 14, 2025 | 000095012325002317 | ||
24 | $961.18M | NUVL, NEWAMSTERDAM PHARMA COMPANY, IRON, DNTH | 13F-HR | Nov 14, 2024 | 000095012324011417 | ||
25 | $910.84M | NUVL, NEWAMSTERDAM PHARMA COMPANY, IRON, DNTH | 13F-HR | Aug 12, 2024 | 000095012324007830 | ||
26 | $1.24B | NEWAMSTERDAM PHARMA COMPANY, NUVL, DNTH, IRON | 13F-HR | May 15, 2024 | 000095012324005471 | ||
27 | $1.04B | NUVL, NEWAMSTERDAM PHARMA COMPANY, PHARVARIS N V, IRON | 13F-HR | Feb 13, 2024 | 000095012324001898 | ||
31 | $894.22M | NUVL, PHARVARIS N V, NEWAMSTERDAM PHARMA COMPANY, SWTX | 13F-HR | Nov 14, 2023 | 000095012323010856 | ||
32 | $970.99M | NUVL, NEWAMSTERDAM PHARMA COMPANY, SWTX, PHARVARIS N V | 13F-HR | Aug 14, 2023 | 000095012323008184 | ||
34 | $801.00K | NEWAMSTERDAM PHARMA COMPANY, NUVL, SWTX, IRON | 13F-HR | May 15, 2023 | 000095012323005321 | ||
33 | $895.00K | SWTX, NUVL, NEWAMSTERDAM PHARMA COMPANY, NTRA | 13F-HR | Feb 14, 2023 | 000095012323002178 | ||
33 | $837.76M | SWTX, NUVL, MRSN, ARQT | 13F-HR | Nov 14, 2022 | 000095012322012270 | ||
35 | $852.70M | SWTX, DVAX, PHARVARIS N V, ARQT | 13F-HR | Aug 15, 2022 | 000095012322009430 | ||
34 | $1.03B | SWTX, DVAX, ARQT, PHARVARIS N V | 13F-HR | May 16, 2022 | 000095012322006412 | ||
34 | $1.26B | SWTX, DVAX, RPID, ARQT | 13F-HR | Feb 14, 2022 | 000095012322002471 | ||
33 | $1.61B | SWTX, DVAX, RPID, AVIR | 13F-HR | Nov 15, 2021 | 000095012321015534 | ||
30 | $1.53B | SWTX, AVIR, DVAX, DRNA | 13F-HR | Aug 16, 2021 | 000095012321011522 | ||
31 | $1.77B | SWTX, AVIR, ARQT, DVAX | 13F-HR | May 17, 2021 | 000095012321006704 | ||
26 | $1.59B | SWTX, AVIR, ARQT, MRSN | 13F-HR | Feb 16, 2021 | 000095012321002146 | ||
22 | $1.07B | SWTX, ARQT, ANNX, DRNA | 13F-HR | Nov 16, 2020 | 000095012320011923 | ||
15 | $954.77M | SWTX, ARQT, DRNA, DVAX | 13F-HR | Aug 14, 2020 | 000095012320008777 | ||
11 | $591.30M | SWTX, ARQT, DRNA, CNST | 13F-HR | May 15, 2020 | 000095012320005061 | ||
10 | $670.54M | SWTX, CNST, DRNA, DVAX | 13F-HR | Feb 14, 2020 | 000095012320002136 | ||
7 | $388.40M | SWTX, DRNA, SOLID BIOSCIENCES INC, REPL | 13F-HR | Nov 14, 2019 | 000095012319011059 | ||
5 | $196.87M | DRNA, REPL, MRNS, SOLID BIOSCIENCES INC | 13F-HR | Aug 14, 2019 | 000095012319007984 | ||
6 | $250.12M | DRNA, REPL, INFLARX NV, MRNS | 13F-HR | May 15, 2019 | 000095012319005099 | ||
6 | $292.64M | DRNA, INFLARX NV, SOLID BIOSCIENCES INC, APTX | 13F-HR | Feb 14, 2019 | 000095012319001853 | ||
6 | $440.63M | DRNA, SOLID BIOSCIENCES INC, APTX, INFLARX NV | 13F-HR | Nov 14, 2018 | 000095012318011520 | ||
5 | $319.13M | DRNA, SOLID BIOSCIENCES INC, INFLARX NV, APTX | 13F-HR | Aug 14, 2018 | 000095012318008490 | ||
4 | $169.60M | DRNA, INFLARX NV, MRNS, SOLID BIOSCIENCES INC | 13F-HR | May 15, 2018 | 000095012318005392 | ||
3 | $152.41M | DRNA, INFLARX NV, MRNS | 13F-HR | Feb 14, 2018 | 000095012318001950 |